Acetylcysteine in the Prevention of Contrast-Induced Nephropathy

Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>

2000 • 18,725 citations

Assessing the quality of reports of randomized clinical trials: Is blinding necessary?

1996 • 17,261 citations

Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients

2000 • 8,612 citations

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials

2001 • 5,358 citations

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement

1999 • 4,736 citations

Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative

2003 • 2,485 citations

Prevention of Radiographic-Contrast-Agent–Induced Reductions in Renal Function by Acetylcysteine

2000 • 1,589 citations

Systematic Review: Why sources of heterogeneity in meta-analysis should be investigated

1994 • 947 citations

The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency

2000 • 749 citations

Effect of the Statistical Significance of Results on the Time to Completion and Publication of Randomized Efficacy Trials

1998 • 628 citations

Acetylcysteine for prevention of contrast nephropathy: meta-analysis

2003 • 487 citations

Acetylcysteine for Prevention of Acute Deterioration of Renal Function Following Elective Coronary Angiography and Intervention

2003 • 448 citations

Acetylcysteine and contrast agent-associated nephrotoxicity

2002 • 383 citations

Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial)

2002 • 365 citations

A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study

2003 • 356 citations

Prevention of radiocontrast nephropathy with N-acetylcysteine in patients with chronic kidney disease: a meta-analysis of randomized, controlled trials

2004 • 352 citations

A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography

2002 • 316 citations

Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure

2002 • 300 citations

Systematic review of the impact of N-acetylcysteine on contrast nephropathy

2004 • 282 citations

Prospective randomized study of N‐acetylcysteine, fenoldopam, and saline for prevention of radiocontrast‐induced nephropathy

2002 • 274 citations

N-Acetylcysteine for the Prevention of Radiocontrast Induced Nephropathy

2004 • 241 citations

Methods for Exploring Heterogeneity in Meta-Analysis

2001 • 232 citations

Investigating causes of heterogeneity in systematic reviews

2002 • 195 citations

Is acetylcysteine effective in preventing contrast-related nephropathy? A meta-analysis

2004 • 193 citations

Evolution of treatment effects over time: Empirical insight from recursive cumulative metaanalyses

2001 • 185 citations

A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: Lack of effect

2004 • 180 citations

Effect sizes in cumulative meta-analyses of mental health randomized trials evolved over time

2004 • 175 citations

Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography A randomized controlled trial and review of the current literature

2004 • 167 citations

Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast

2003 • 154 citations

Meta-analysis of randomized clinical trials on the usefulness of acetylcysteine for prevention of contrast nephropathy**The opinions, interpretations, conclusions, and recommendations expressed in this article are those of the authors and are not necessarily endorsed by the U.S. Army.

2003 • 131 citations

N-acetylcysteine for the prevention of contrast-induced nephropathy

2005 • 118 citations

Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography

2003 • 112 citations

N‐acetylcysteine prophylaxis significantly reduces the risk of radiocontrast‐induced nephropathy: Comprehensive meta‐analysis

2005 • 112 citations

N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up

2004 • 110 citations

The effect of N-acetylcysteine on renal function, nitric oxide, and oxidative stress after angiography

2003 • 105 citations

Effect of N-acetylcysteine for prevention of contrast nephropathy in patients with moderate to severe renal insufficiency: a randomized trial

2004 • 97 citations

Prevention of contrast-induced nephropathy in vascular patients undergoing angiography: A randomized controlled trial of intravenous N-acetylcysteine

2004 • 96 citations

Role of N‐acetylcysteine in prevention of contrast‐induced nephropathy after cardiovascular procedures: A meta‐analysis

2004 • 89 citations

Prophylaxis of contrast‐induced nephropathy in patients undergoing coronary angiography

2003 • 88 citations

Challenges in Systematic Reviews of Therapeutic Devices and Procedures

2005 • 68 citations

Abbreviated Dosing of N‐Acetylcysteine Prevents Contrast‐Induced Nephropathy After Elective and Urgent Coronary Angiography and Intervention

2004 • 67 citations

The role of N-acetylcysteine in preventing radiographic contrast-induced nephropathy

2004 • 50 citations

Acetylcysteine, coronary procedure and prevention of contrast-induced worsening of renal function

2003 • 49 citations

[Contrast nephropathy in cardiac procedures: no advantages with prophylactic use of N-acetylcysteine (NAC)].

2002 • 42 citations

Prevention of radiocontrast-induced nephropathy with N-acetylcysteine in patients undergoing coronary angiography.

2003 • 37 citations

[Absence of nephro-protective effect of acetylcysteine in patients with chronic renal failure investigated by coronary angiography].

2003 • 17 citations

Effectiveness of acetylcysteine on preventing renal dysfunction in patients undergoing coronary procedures.

2004 • 2 citations